Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

203.23 +3.21 (+1.61%)

Delayed Quote Updated: 3:19 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

28 29 Next >

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise ↗

June 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Are We Heading Towards Recession? ↗

June 22, 2022

Transportation, as the ultimate demand indicator, could also help us determine the fate of recession.

Via Talk Markets

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗

June 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Demand Destruction as Seen in the Transportation Sector ↗

June 21, 2022

Transportation IYT opened higher, ran to its 200-week moving average, and retreated, albeit whilst remaining green on the day.

Via Talk Markets

What’s Next For Biotech And Healthcare ↗

June 13, 2022

Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform.

Via Talk Markets

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial ↗

June 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

A Moment Of Truth - Ways To Help You Deal With A New Reality ↗

June 19, 2022

The truth can be difficult to hear. This week, investors had to deal with a heavy dose of truth about the state of the economy. Based on the markets’ response, it was painfully unexpected and...

Via Talk Markets

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗

June 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK ↗

June 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Can the Fed Control Inflation with Higher Rates? ↗

June 15, 2022

Today’s rally in equities might be met with further selling very soon once the market realizes that the Fed cannot go far enough.

Via Talk Markets

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data ↗

June 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

For Signs of a Relief Rally, Watch the S&P 500 v. Retail ↗

June 14, 2022

With inflation on everyone’s lips and the price of gas and food showing no signs of abating, the retail sector is the key to assessing where the equity market goes from here.

Via Talk Markets

The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate ↗

June 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why This Biotech ETF May Be About to Break Out ↗

June 09, 2022

There’s a chance shares of the iShares Biotechnology ETF (NASDAQ: IBB) may be about to break out. They are testing a resistance level. If they can get above it, a new uptrend may form.

Via Benzinga

Watch For The Nasdaq 100 and S&P 500 to Clear Their Mini Ranges ↗

June 08, 2022

As the current leader of the major indices, IWM has been playing a very important role in the overall market direction.

Via Talk Markets

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗

June 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Are Gold And Silver Ready for A Momentum Breakout? ↗

June 07, 2022

Currently, SLV is looking to break over its 200-DMA.

Via Talk Markets

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study ↗

June 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

3 Things Need to Align for The Next Big Market Move ↗

June 06, 2022

Currently, the small-cap index Russell 2000 is leading in momentum compared to the S&P 500 and the Nasdaq 100. Last Thursday is an important day for each of the indices as it represents the high of the...

Via Talk Markets

Musk Stirs Up A Hornet's Nest In Epstein Case, Apple WWDC Expectations, Kim Jong-Un Goes Ballistic And More: 5 Key Stories You May Have Missed From This Weekend ↗

June 06, 2022

Just as investors were hoping for an inflection higher, a strong non-farm payroll report proved to be the undoing of markets in the week ending June 3. Investors are still left to grapple with a fluid...

Via Benzinga

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

Is the Stock Market Looking for Temporary Relief? ↗

June 02, 2022

There is no doubt that the stock market is in a tough spot fundamentally with increasing interest rates, inflation, and a downward trend from the technical side.

Via Talk Markets

What Does a Trading Range Look Like? ↗

June 01, 2022

Buying ahead of taking out last week's high was premature. Getting overly negative unless we fail last week’s low is equally premature.

Via Talk Markets

3 Biotech Stocks to Buy Before They Boom ↗

June 01, 2022

It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.

Via InvestorPlace

Can Big Tech Save the Day Again? ↗

May 31, 2022

Nasdaq spent most of the day green, only to close down .18% in the last few minutes of the session.

Via Talk Markets

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗

May 31, 2022

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...

Via Benzinga

Bill Gates' Tesla Short Bet Balloons, Astute Investors Reap Luna Windfall, Giga Shanghai Update And More: 5 Key Stories You May Have Missed Memorial Day Weekend ↗

May 31, 2022

The market is set to open following the long weekend in observance of the Memorial Day holiday. As investors look ahead to a fresh trading week, hoping for an extension of the...

Via Benzinga

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More ↗

May 30, 2022

Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...

Via Benzinga

As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats ↗

May 30, 2022

The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data...

Via Benzinga

The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review ↗

May 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

iShares Biotechnology ETF (NQ:IBB)

All News about iShares Biotechnology ETF

Starting at /week.